Vaccines against virally induced cancers.
Saved in:
| Imprint: | Chichester ; New York : J. Wiley, 1994. |
|---|---|
| Description: | xi, 281 p. : ill., map ; 24 cm. |
| Language: | English |
| Series: | Ciba Foundation symposium ; 187 Ciba Foundation symposium new ser., 187. |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/1741765 |
MARC
| LEADER | 00000nam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 1741765 | ||
| 005 | 20060425141700.0 | ||
| 008 | 950511s1994 enkab b 101 0 eng c | ||
| 003 | ICU | ||
| 010 | |a 94033207 | ||
| 020 | |a 0471950262 : |c 147.50 | ||
| 035 | |a (ICU)BID19991076 | ||
| 035 | |a (OCoLC)31075238 | ||
| 040 | |a DNLM/DLC |c DLC |d DLC |d ICU |d OrLoB-B |d OCoLC | ||
| 041 | 0 | |a eng | |
| 050 | 0 | 0 | |a RC268.57 |b .V33 1994 |
| 060 | 0 | |a W3 C161F v. 187 1994 |a QZ200 V116 1994 | |
| 082 | 0 | 0 | |a 616.99/4079 |2 20 |
| 245 | 0 | 0 | |a Vaccines against virally induced cancers. |
| 260 | |a Chichester ; |a New York : |b J. Wiley, |c 1994. | ||
| 300 | |a xi, 281 p. : |b ill., map ; |c 24 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a Ciba Foundation symposium ; |v 187 | |
| 500 | |a "Ciba Foundation"--Cover. | ||
| 500 | |a Symposium held at the Ciba Foundation, London, 15-17 March 1994, based on a proposal by Ian Frazer. | ||
| 504 | |a Includes bibliographical references and indexes. | ||
| 505 | 2 | 0 | |t Introduction / |r I. Frazer -- |t Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response / |r D. J. Moss, S. R. Burrows, A. Suhrbier and R. Khanna -- |t The host response to lesions induced by human papillomavirus / |r M. Stanley, N. Coleman and M. Chambers -- |t Human T cell lymphotropic virus: necessity for and feasibility of a vaccine / |r G. de The, R. Bomford, M. Kazanji and F. Ibrahim -- |t Vaccination against cutaneous and mucosal papillomavirus in cattle / |r M. S. Campo and W. F. H. Jarrett -- |t Strategies for studying mouse and human immune responses to human papillomavirus type 16 / |r P. C. L. Beverley, E. Sadovnikova, X. Zhu, J. Hickling, L. Gao, B. Chain, S. Collins, L. Crawford, K. Vousden and H. J. Stauss -- |t Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides / |r C. J. M. Melief and W. M. Kast -- |t Hepatitis B virus infection, the immune response and hepatocellular carcinoma / |r D. R. Milich, J. Jones, J. Hughes and T. Maruyama -- |t The role of superantigens in the immunobiology of retroviruses / |r B. T. Huber, U. Beutner and M. Subramanyam -- |t Assembly and transport of class I MHC-peptide complexes / |r P. Cresswell, M. J. Androlewicz and B. Ortmann -- |t Induction and regulation of CD4[superscript +] T cell subsets / |r F. Y. Liew -- |t Propagation of mouse and human T cells with defined antigen specificity and function / |r P. A. Cohen, D. H. Fowler, H. Kim, R. L. White, B. J. Czerniecki, C. Carter, R. E. Gress and S. A. Rosenberg -- |t Immunity to the HER-2/neu oncogenic protein / |r M. L. Disis, H. Bernhard, J. R. Gralow, S. L. Hand, S. R. Emery, E. Calenoff and M. A. Cheever -- |t Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapy / |r P. D. Greenberg, B. Nelson, M. Gilbert, A. Sing, C. Yee, M. Jensen and S. R. Riddell -- |t Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses / |r A. Y. C. Huang, P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll and H. Levitsky -- |t Evasion of host immune responses by tumours and viruses / |r P. C. Doherty, R. A. Tripp and J. W. Sixbey. |
| 650 | 0 | |a Viral carcinogenesis |v Congresses. |0 http://id.loc.gov/authorities/subjects/sh2010117949 | |
| 650 | 0 | |a Viral vaccines |v Congresses. |0 http://id.loc.gov/authorities/subjects/sh2010117950 | |
| 650 | 0 | |a Cancer |x Immunotherapy |v Congresses. |0 http://id.loc.gov/authorities/subjects/sh2009118244 | |
| 650 | 1 | 2 | |a Neoplasms |x immunology |v congresses. |
| 650 | 1 | 2 | |a Tumor Virus Infections |x immunology |v Congresses. |
| 650 | 2 | 2 | |a Vaccines |x immunology |v congresses. |
| 650 | 2 | 2 | |a Oncogenic Viruses |x pathogenicity |v Congresses. |
| 650 | 7 | |a Cancer |x Immunotherapy. |2 fast |0 http://id.worldcat.org/fast/fst00845386 | |
| 650 | 7 | |a Viral carcinogenesis. |2 fast |0 http://id.worldcat.org/fast/fst01167600 | |
| 650 | 7 | |a Viral vaccines. |2 fast |0 http://id.worldcat.org/fast/fst01167621 | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 http://id.worldcat.org/fast/fst01423772 | |
| 700 | 1 | |a Frazer, I. H. |q (Ian H.) |0 http://id.loc.gov/authorities/names/n94802741 |1 http://viaf.org/viaf/70631464 | |
| 710 | 2 | 0 | |a Ciba Foundation. |0 http://id.loc.gov/authorities/names/n79023182 |1 http://viaf.org/viaf/121841430 |
| 830 | 0 | |a Ciba Foundation symposium |v new ser., 187. |0 http://id.loc.gov/authorities/names/n83742130 | |
| 901 | |a ToCBNA |a Analytic | ||
| 903 | |a HeVa | ||
| 903 | |a Hathi | ||
| 929 | |a cat | ||
| 999 | f | f | |i ab883ad1-b587-5f4e-a5db-2f64849fcec5 |s 7364debf-0dd7-59f8-942a-235b542875fc |
| 928 | |t Library of Congress classification |a R850.A1C5 n.s. v.187 |l ASR |c ASR-SciASR |i 2297867 | ||
| 927 | |t Library of Congress classification |a R850.A1C5 n.s. v.187 |l ASR |c ASR-SciASR |g Analytic |e CRERAR |b A42487007 |i 3262249 | ||
